GVP Module Safety Communication

First Page		Document Content
Date: 2013-07-21 06:39:02 Pharmaceutical sciences Pharmacovigilance European Medicines Agency Patient safety Summary of Product Characteristics Adverse effect Qualified Person Responsible For Pharmacovigilance EudraVigilance Medicine Health Pharmacology		GVP Module Safety Communication Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 179,10 KB Share Document on Facebook

	The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS DocID: 1vrLd - View Document
	7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme DocID: 1vlIp - View Document
	The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP DocID: 1ucvu - View Document
	2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use DocID: 1sVev - View Document
	European Medicines Agency: Celebrating 20 years DocID: 1sUY9 - View Document